Apnex Medical Inc.
Division of Cyberonics Inc./Apnex Medical Inc.
Latest From Apnex Medical Inc.
With half or more of all diagnosed obstructive sleep apnea patients who need continuous positive airway pressure machines unwilling or unable to use these devices, there’s a large unmet need for an alternative treatment. Startups are rising to the challenge with neuromodulation platforms, a mouthguard-like suction device, a nasal device with microblowers, and a vibrating device that nudges patients to turn on their sides.
An estimated 15 million Americans have obstructive sleep apnea severe enough to warrant treatment, but this field has been chronically underserved by traditional continuous positive airway pressure systems that are inconvenient and uncomfortable to use. To address this problem, CPAP manufacturers are making design improvements to optimize comfort and compliance; at the same time, promising new technologies are emerging – including neurostimulation devices for OSA – that could help reshape the future management of this often overlooked, but serious disorder.
START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
- Implantable Devices
- Monitoring Equipment & Devices
- Therapeutic Areas
- Respiratory, Pulmonary
- North America
- Parent & Subsidiaries
- Cyberonics Inc.
- Senior Management
Bob Atkinson, CEO
Steve Bolea, VP, R&D
- Contact Info
Apnex Medical Inc.
Phone: (651) 757-4300
2890 Centre Pointe Dr.
St. Paul, MN 55113
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.